ReviewFrontiers in oncology2026
Ultrasonography of the recurrent laryngeal nerve in thyroid cancer: advances in clinical application and research progress.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rising incidence and detection rate of thyroid cancer have led to a concomitant increase in the number of thyroidectomy procedures performed annually. Among the postoperative complications, recurrent laryngeal nerve injury (RLNI) remains a major factor affecting patients' quality of life. In pursuit of precision therapeutic strategies and reduced nerve injury rates,clinicians have shown growing interest in the recurrent laryngeal nerve(RLN). In recent years, high-frequency ultrasound (HFUS) has been increasingly incorporated into the perioperative management of thyroidectomy. This study is the first to address RLN management during the perioperative period for thyroid cancer. The ultrasonographic characteristics of the RLN are systematically reviewed, with particular emphasis on the clinical utility of HFUS in preoperative screening, intraoperative monitoring, and postoperative follow-up. We also discuss the inherent limitations of this technique and outline future directions. Despite these promising advances, significant challenges persist in ensuring the accuracy and standardization of ultrasonographic examinations across diverse patient populations. In conclusion, this review highlights the transformative potential of HFUS in optimizing perioperative neural monitoring and functional evaluation for thyroid cancer. However, it also notes that ultrasound cannot currently replace laryngoscopy or intraoperative nerve monitoring (IONM), though it serves as a valuable complementary tool with clear clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.